Latest in News & Research
Chronic Pruritus Prevalent Among Older Adults
Atopic dermatitis and psychological symptoms were associated with greatest impairment in pruritus-specific QoL
Introducing Amy Jones and PANP360: A New Era for PAs and NPs in Dermatology
PANP360 brings dermatology PAs and NPs a place to learn, connect, and grow—clinically and as whole people.
Prevalence of Primary Epithelioid Sarcoma Is 0.49 per 100,000 in the U.S.
Prevalence was highest among Whites, lowest among American Indians; highest prevalence seen for those aged 35 to 39 years
Study Compares Treatment Modalities for Management of Keloids
Intralesional triamcinolone acetonide had greatest efficacy, with relatively favorable side effect profile
Melanoma Clusters Identified in Pennsylvania Counties Near Farmland
Increase in cultivated land and herbicide-treated acreage independently linked to increase in melanoma incidence
Eczema Symptoms Do Not Differ With Daily, Weekly Bathing
No significant difference seen in mean POEM score for weekly versus daily bathing over four weeks
Pregnancy-Associated Melanomas Exhibit Distinct Clinicopathologic Features
Eighty percent of PAMs are superficial spreading; 57.1 percent developed on preexisting nevus
Antibiotic Exposure Linked to Biologic Discontinuation in Psoriasis
Stronger effect seen for multiple dispensations, suggesting dose-response relationship
Icotrokinra Beneficial for Adults, Teens With Plaque Psoriasis
Icotronkinra results in significantly higher incidence of complete skin clearance at week 16 than placebo
ACAAI: Eczema Onset, Severity Can Affect Child's Ability to Outgrow Food Allergy
Onset of eczema between 4 and 6 months, greater severity, and longer duration linked to lower likelihood of outgrowing allergies
ACAAI: COVID-19 Vaccination Reduces Risk for Multiple Infections in Children With Atopic Dermatitis
Reduced risks seen for multiple infections and for allergic complications, including asthma, allergic rhinitis, contact dermatitis
ACAAI: Breast Implant Complications, Revision Surgery More Likely in Patients With Eczema
Patients with atopic diseases also have increased risks for complications, revision surgery after bone grafting
FDA Warns 18 Websites for Selling Fake Botox Linked to Injuries
Botox should only be given by licensed medical professionals using FDA-approved products, the agency warned
Lower Autoantibody Positivity Seen With Herbal Intake Before Dermatomyositis
Patients with dermatomyositis who used immunostimulatory herbs before onset have lower rates of MAA, MSA, ANA positivity
Drop in Lymph Node Dissection Seen for Melanoma Patients With Positive SLNs
Decrease seen from 2012 to 2021 in patients with melanoma with two or more positive sentinel lymph nodes
Two HLA Class I Alleles Independently Linked to Allopurinol-Induced SCARs
HLA-B*58:01 and HLA-A*34:02 linked to increased risk, while no HLA class II alleles were identified
FDA Issues Safety Alert for Radiofrequency Microneedling
Reported complications include severe burns, scarring and nerve damage, sometimes requiring surgery
Early Change in Family Structure May Increase Risk for Psoriasis
Children experiencing the psychological stress of 'new family structure' in first year of life have increased psoriasis risk
NEWS ALERT: Tralokinumab Achieves Complete Clearance After Multiple Treatment Failures in Atopic Dermatitis
A real-world case highlights the therapeutic potential of tralokinumab in patients with difficult-to-treat AD
JAKi Treatment Not Linked to Height Differences in Pediatric Patients
No significant differences in height seen for JAKi exposure in atopic dermatitis, juvenile arthritis, and inflammatory bowel disease
AI-Assisted LC-OCT Improves Dermatologists' Diagnostic Performance for BCC
Particular benefit seen for those with less LC-OCT experience, bridging a two-year gap of expertise
Gene Expression Profile Test IDs Patients Who Can Skip SLNB in Melanoma
Of patients identified as low risk by combined clinicopathological factors and GEP test, only 7.1 percent were SLN-positive
Neutrogena Makeup Wipes Recalled Due to Possible Bacteria
The U.S. Food and Drug Administration (FDA) has issued a Class II risk level for certain Neutrogena makeup remover wipes
24 of 1274